Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Casper, WY MSA — September 2026
Casper jobs shrink while pay per worker climbs — talent stays scarce.
Natrona County lost roughly 800 jobs year-over-year even as payroll rose 3.3%, and with only 88 open biotech roles statewide, Life Sci leaders should treat Wyoming as a sourcing desert requiring CRO/CDMO partnerships or remote hiring for specialized talent.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Natrona County unemployment: 2.6%–3.0% — vs. 4.1% national rate, August 2026
- Nonfarm job change, Natrona County: -800 jobs YoY — Five straight months of losses through Jan. 2026
- Casper avg. hourly wage: $28.93 — vs. $33.54 national average, May 2025
- Open biotech roles, statewide: 88 listings — Glassdoor count vs. thousands in biotech hub metros
Key takeaways
Casper's job losses mask a tightening, not loosening, market.
Natrona County shed roughly 800 jobs year-over-year through January even as total payroll rose 3.3%, suggesting employers are concentrating spend on fewer, more essential workers rather than expanding headcount. Life Sci employers eyeing the metro should expect premium pricing for any skilled hire, not a buyer's market.
Local wage data understates what scientific talent actually costs.
Casper's average hourly wage of $28.93 sits well below the $33.54 national average, but Wyoming's statewide scientist pay of roughly $47.82/hour shows specialized roles decouple sharply from the metro baseline. Benchmarking against the broad local average risks underpricing any regulatory, quality, or lab-science requisition.
Wyoming's biotech footprint is too thin to anchor a build strategy.
Glassdoor shows just 88 open biotech roles statewide and BioSpace lists a single posting, with Hoskinson Biotechnology in Gillette among the few visible employers. Organizations weighing in-house expansion versus CDMO partnership should treat Wyoming as a sourcing desert for anything beyond entry-level clinical lab positions.
National layoffs aren't loosening the specialist pool locally.
September's biopharma layoffs (BioMarin, Bristol Myers) concentrate in consolidation functions at large coastal employers, not the generalist or regional talent that might relocate to Wyoming. Casper-based organizations shouldn't expect displaced biopharma talent to meaningfully deepen the local candidate pipeline.
Median advertised pay by role — Casper, WY MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $127,063 | $134,534 | Significant decline | $131,354 |
| Clinical Research Associate * | $103,846 | $115,029 | $126,389 | Stable | $90,956 |
| Lab Technician * | $37,261 | $37,853 | $37,853 | Significant decline | $47,402 |
| Regulatory Affairs Specialist * | $87,596 | $88,634 | $91,265 | Significant decline | $104,000 |
| Clinical Data Manager * | $96,908 | $105,049 | $106,909 | Significant decline | $123,031 |
| Biostatistician * | $99,597 | $136,186 | $145,002 | Significant decline | $133,322 |
| Validation Engineer | — | — | — | No data | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Natrona County unemployment held near 2.6%–3.0% through mid-2026, but total nonfarm employment fell to 40,200 in January, marking five consecutive months of job losses even as payroll dollars rose 3.3% year-over-year — a sign that shrinking headcount is being offset by richer pay for those who remain. Casper's thin life sciences employment base, anchored by scattered clinical lab and healthcare roles rather than any manufacturing or CDMO cluster, means specialized scientific and regulatory hiring here tracks national scarcity dynamics far more than local labor supply.
What it means
Casper's labor market offers little practical bench strength for in-house regulatory, quality, or CMC hiring — the metro shows essentially no biotech or pharma manufacturing density, so any build-vs-outsource calculus for Wyoming-based operations should assume candidate pools near zero for credentialed roles above entry-level clinical lab work. National premiums for scarce specialties like regulatory affairs ($320K–$580K for VP-level) and cell/gene CMC leadership make remote or hub-based hiring, rather than local recruitment, the realistic path for Casper-area organizations needing that expertise. Consider evaluating CRO and CDMO partnerships for any quality-intensive or regulatory-heavy function rather than planning local headcount builds that the metro's labor supply cannot support.
Looking ahead
Early indicator: Watch whether Natrona County's five-month streak of job losses extends into Q3 data (due November) — a sixth or seventh consecutive decline would suggest structural contraction rather than a temporary dip, affecting assumptions about local support-staff availability for any life sci operation.
Expected: BLS releases September metro-level unemployment and employment figures in early November; confirm whether Natrona County's sub-state unemployment advantage (2.6% vs. 4.1% national) is narrowing as job counts fall.
Emerging pressure point: National regulatory affairs and CMC compensation continues climbing as EU MDR and FDA pathway changes elevate the role's strategic weight — any Wyoming-based organization competing for this talent should expect to anchor offers to national, not regional, pay data.
Worth watching: Sales tax collections in Natrona County rose nearly 6% despite job losses, hinting at consumer resilience that could support healthcare and diagnostics demand locally — monitor whether this translates into clinical lab or diagnostics hiring activity in Q4.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.